scholarly journals A novel and innovative device to retract rectum during radiation therapy of pelvic tumors

2018 ◽  
Vol 20 (1) ◽  
pp. 194-199 ◽  
Author(s):  
E. Ishmael Parsai ◽  
Ahmadreza Jahadakbar ◽  
Hossein Lavvafi ◽  
Mohammad Elahinia
2017 ◽  
Vol 9 (2) ◽  
pp. 19 ◽  
Author(s):  
O.S. Streltsova ◽  
A.V. Maslennikova ◽  
K.E. Yunusova ◽  
V.V. Dudenkova ◽  
E.B. Kiseleva ◽  
...  

2018 ◽  
Vol 13 (1) ◽  
Author(s):  
Tharcisio Machado Coelho ◽  
Ricardo César Fogaroli ◽  
Antonio Cassio Assis Pellizzon ◽  
Douglas Guedes De Castro ◽  
Guilherme Rocha Melo Gondim ◽  
...  

2008 ◽  
Vol 67 (5) ◽  
pp. AB202-AB203 ◽  
Author(s):  
Julie Yang ◽  
Amar R. Deshpande ◽  
Daniel A. Sussman ◽  
May Abdel-Wahab ◽  
B.-Chen Wen ◽  
...  

2010 ◽  
Vol 5 (1) ◽  
Author(s):  
Robson Ferrigno ◽  
Adriana Santos ◽  
Lidiane C Martins ◽  
Eduardo Weltman ◽  
Michael J Chen ◽  
...  

Author(s):  
F. Campostrini ◽  
M. Gregianin ◽  
F. Lonardi ◽  
L. Rampin ◽  
G.A. Agus ◽  
...  

2016 ◽  
Vol 2016 ◽  
pp. 1-5
Author(s):  
Tomas Mujo ◽  
Erin Priddy ◽  
John J. Harris ◽  
Eric Poulos ◽  
Mahmoud Samman

Active extravasation via an arterioureteral fistula (AUF) is a rare and life-threatening emergency that requires efficient algorithms to save a patient’s life. Unfortunately, physicians may not be aware of its presence until the patient is in extremis. An AUF typically develops in a patient with multiple pelvic and aortoiliac vascular surgeries, prior radiation therapy for pelvic tumors, and chronic indwelling ureteral stents. We present a patient with a left internal iliac arterial-ureteral fistula and describe the evolution of management and treatment algorithms based on review of the literature.


2018 ◽  
Vol 102 (3) ◽  
pp. S131-S132
Author(s):  
J. Zhang ◽  
S.N. LIM ◽  
E.E. Ahunbay ◽  
W.A. Hall ◽  
B.A. Erickson ◽  
...  

2013 ◽  
Vol 31 (15_suppl) ◽  
pp. 10520-10520
Author(s):  
Kaitlyn Jane Kelly ◽  
Sam S. Yoon ◽  
Deborah Kuk ◽  
Li-Xuan Qin ◽  
Katerina Dukleska ◽  
...  

10520 Background: Radiation therapy (RT) for retroperitoneal and pelvic sarcomas (RPS) is controversial. We examined the association of perioperative, advanced modality RT on outcomes in primary RPS. Methods: Prospectively maintained databases were reviewed to compare primary RPS patients (pts) treated at two institutions between 2003 and 2011. Clinicopathologic variables were analyzed with endpoints of local recurrence-free survival (LRFS) and disease-specific survival (DSS). Results: At one institution 172 pts were treated with surgery alone while at the other 32 pts were treated with surgery and perioperative proton beam or intensity-modulated RT ± intraoperative RT. The groups were similar in age, gender, tumor grade, tumor size, and margin status (p = NS). The RT group had a lower percentage of retroperitoneal versus pelvic tumors and leiomyo/liposarcoma versus other histologies (p < 0.05). Median follow-up was 38.7 months (36.9 for RT group, 38.8 for surgery alone). Five-year predicted LRFS was 91% (95% CI, 79-100%) in the RT group and 65% (57-74%) in the surgery only group (p = 0.06). RT was marginally significant in univariate analysis of LRFS. Upon adjusting for univariate predictors, RT was significantly associated with better LRFS (p = 0.046; Table). Five-year predicted DSS was 93% (95% CI, 82-100%) in the RT group and 84% (78-91%) in the surgery-only group (p = 0.25). The only independent predictor of DSS was age. Morbidity was higher in the RT group (41% vs 17%; p= 0.004). Conclusions: In this retrospective study, the addition of advanced modality RT to surgery for primary RPS was associated with a reduced risk of local recurrence, although this did not translate into a statistically significant improvement in DSS. This treatment strategy warrants further investigation in a randomized trial. [Table: see text]


Sign in / Sign up

Export Citation Format

Share Document